PALO ALTO, Calif.--Incyte Pharmaceuticals said it has finalized an agreement to contribute to the Human Genome Project by performing DNA sequencing for the University of Washington. The university, which named Incyte as a collaborator in a grant proposal it made to the US National Human Genome Research Institute earlier this year, will refine the data Incyte generates and deposit it to GenBank. The university had requested $3 million to budget for Incyte’s sequencing services.
Incyte last week also announced that it would link its LifeArray gene expression software with Spotfire’s Decision Support Software. The combined product is designed to enable researchers to perform detailed visual analysis of gene expression data and to integrate results across multiple scientific or patent databases.